1.

Impact of Colonoscopy Bowel Preparation Quality on Follow-up Interval Recommendations for Average-risk Patients With Normal Screening Colonoscopies: Data From the New Hampshire Colonoscopy Registry.

Butterly LF, Nadel MR, Anderson JC, Robinson CM, Weiss JE, Lieberman D, Shapiro JA.

J Clin Gastroenterol. 2018 Aug 13. doi: 10.1097/MCG.0000000000001115. [Epub ahead of print]

PMID:
30106836
2.

Colorectal cancer screening in the United States: Trends from 2008 to 2015 and variation by health insurance coverage.

de Moor JS, Cohen RA, Shapiro JA, Nadel MR, Sabatino SA, Robin Yabroff K, Fedewa S, Lee R, Paul Doria-Rose V, Altice C, Klabunde CN.

Prev Med. 2018 Jul;112:199-206. doi: 10.1016/j.ypmed.2018.05.001. Epub 2018 May 3.

PMID:
29729288
3.

Multilevel Small-Area Estimation of Colorectal Cancer Screening in the United States.

Berkowitz Z, Zhang X, Richards TB, Nadel M, Peipins LA, Holt J.

Cancer Epidemiol Biomarkers Prev. 2018 Mar;27(3):245-253. doi: 10.1158/1055-9965.EPI-17-0488.

PMID:
29500250
4.

Pregnancy and End-Stage Renal Disease.

Tangren J, Nadel M, Hladunewich MA.

Blood Purif. 2018;45(1-3):194-200. doi: 10.1159/000485157. Epub 2018 Jan 26.

5.

A Comparison of Fecal Immunochemical and High-Sensitivity Guaiac Tests for Colorectal Cancer Screening.

Shapiro JA, Bobo JK, Church TR, Rex DK, Chovnick G, Thompson TD, Zauber AG, Lieberman D, Levin TR, Joseph DA, Nadel MR.

Am J Gastroenterol. 2017 Nov;112(11):1728-1735. doi: 10.1038/ajg.2017.285. Epub 2017 Oct 10.

PMID:
29016558
6.

Recommendations From the International Colorectal Cancer Screening Network on the Evaluation of the Cost of Screening Programs.

Subramanian S, Tangka FK, Hoover S, Nadel M, Smith R, Atkin W, Patnick J; International Colorectal Cancer Screening Network.

J Public Health Manag Pract. 2016 Sep-Oct;22(5):461-5. doi: 10.1097/PHH.0000000000000386.

7.

A Matter of Choice: Opportunities and Obstacles Facing People with ESRD.

Feder J, Nadel MV, Krishnan M.

Clin J Am Soc Nephrol. 2016 Mar 7;11(3):536-8. doi: 10.2215/CJN.04470415. Epub 2015 Nov 9.

8.

Colorectal Cancer Screening in US Seniors Ages 76-84 Years.

Klabunde CN, Shapiro JA, Kobrin S, Nadel MR, Zapka JM.

J Community Health. 2015 Aug;40(4):769-79. doi: 10.1007/s10900-015-9998-z.

9.

Moving forward: using the experience of the CDCs' Colorectal Cancer Screening Demonstration Program to guide future colorectal cancer programming efforts.

Seeff LC, DeGroff A, Joseph DA, Royalty J, Tangka FK, Nadel MR, Plescia M.

Cancer. 2013 Aug 1;119 Suppl 15:2940-6. doi: 10.1002/cncr.28155.

10.

Assessing screening quality in the CDC's Colorectal Cancer Screening Demonstration Program.

Nadel MR, Royalty J, Shapiro JA, Joseph D, Seeff LC, Lane DS, Dwyer DM.

Cancer. 2013 Aug 1;119 Suppl 15:2834-41. doi: 10.1002/cncr.28164.

11.

Clinical outcomes from the CDC's Colorectal Cancer Screening Demonstration Program.

Seeff LC, Royalty J, Helsel WE, Kammerer WG, Boehm JE, Dwyer DM, Howe WR Jr, Joseph D, Lane DS, Laughlin M, Leypoldt M, Marroulis SC, Mattingly CA, Nadel MR, Phillips-Angeles E, Rockwell TJ, Ryerson AB, Tangka FK.

Cancer. 2013 Aug 1;119 Suppl 15:2820-33. doi: 10.1002/cncr.28163.

12.

European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication.

European Colorectal Cancer Screening Guidelines Working Group, von Karsa L, Patnick J, Segnan N, Atkin W, Halloran S, Lansdorp-Vogelaar I, Malila N, Minozzi S, Moss S, Quirke P, Steele RJ, Vieth M, Aabakken L, Altenhofen L, Ancelle-Park R, Antoljak N, Anttila A, Armaroli P, Arrossi S, Austoker J, Banzi R, Bellisario C, Blom J, Brenner H, Bretthauer M, Camargo Cancela M, Costamagna G, Cuzick J, Dai M, Daniel J, Dekker E, Delicata N, Ducarroz S, Erfkamp H, Espinàs JA, Faivre J, Faulds Wood L, Flugelman A, Frkovic-Grazio S, Geller B, Giordano L, Grazzini G, Green J, Hamashima C, Herrmann C, Hewitson P, Hoff G, Holten I, Jover R, Kaminski MF, Kuipers EJ, Kurtinaitis J, Lambert R, Launoy G, Lee W, Leicester R, Leja M, Lieberman D, Lignini T, Lucas E, Lynge E, Mádai S, Marinho J, Maučec Zakotnik J, Minoli G, Monk C, Morais A, Muwonge R, Nadel M, Neamtiu L, Peris Tuser M, Pignone M, Pox C, Primic-Zakelj M, Psaila J, Rabeneck L, Ransohoff D, Rasmussen M, Regula J, Ren J, Rennert G, Rey J, Riddell RH, Risio M, Rodrigues V, Saito H, Sauvaget C, Scharpantgen A, Schmiegel W, Senore C, Siddiqi M, Sighoko D, Smith R, Smith S, Suchanek S, Suonio E, Tong W, Törnberg S, Van Cutsem E, Vignatelli L, Villain P, Voti L, Watanabe H, Watson J, Winawer S, Young G, Zaksas V, Zappa M, Valori R.

Endoscopy. 2013;45(1):51-9. doi: 10.1055/s-0032-1325997. Epub 2012 Dec 4.

13.

Use of lung cancer screening tests in the United States: results from the 2010 National Health Interview Survey.

Doria-Rose VP, White MC, Klabunde CN, Nadel MR, Richards TB, McNeel TS, Rodriguez JL, Marcus PM.

Cancer Epidemiol Biomarkers Prev. 2012 Jul;21(7):1049-59. doi: 10.1158/1055-9965.EPI-12-0343. Epub 2012 May 9.

14.

Patterns of colorectal cancer test use, including CT colonography, in the 2010 National Health Interview Survey.

Shapiro JA, Klabunde CN, Thompson TD, Nadel MR, Seeff LC, White A.

Cancer Epidemiol Biomarkers Prev. 2012 Jun;21(6):895-904. doi: 10.1158/1055-9965.EPI-12-0192. Epub 2012 Apr 6.

15.

Toward standardizing and reporting colorectal cancer screening indicators on an international level: The International Colorectal Cancer Screening Network.

Benson VS, Atkin WS, Green J, Nadel MR, Patnick J, Smith RA, Villain P; International Colorectal Cancer Screening Network.

Int J Cancer. 2012 Jun 15;130(12):2961-73. doi: 10.1002/ijc.26310. Epub 2011 Aug 30.

16.

Trends in colorectal cancer test use among vulnerable populations in the United States.

Klabunde CN, Cronin KA, Breen N, Waldron WR, Ambs AH, Nadel MR.

Cancer Epidemiol Biomarkers Prev. 2011 Aug;20(8):1611-21. doi: 10.1158/1055-9965.EPI-11-0220. Epub 2011 Jun 8.

17.

Improving colorectal cancer screening outcomes: proceedings of the second meeting of the International Colorectal Cancer Screening Network, a global quality initiative.

Atkin WS, Benson VS, Green J, Monk CR, Nadel MR, Patnick J, Smith RA, Villain P.

J Med Screen. 2010;17(3):152-7. doi: 10.1258/jms.2010.010002.

PMID:
20956726
18.

Quality assessment of colonoscopy reporting: results from a statewide cancer screening program.

Li J, Nadel MR, Poppell CF, Dwyer DM, Lieberman DA, Steinberger EK.

Diagn Ther Endosc. 2010;2010. pii: 419796. doi: 10.1155/2010/419796. Epub 2010 Sep 28.

19.

The quality of colonoscopy services--responsibilities of referring clinicians: a consensus statement of the Quality Assurance Task Group, National Colorectal Cancer Roundtable.

Fletcher RH, Nadel MR, Allen JI, Dominitz JA, Faigel DO, Johnson DA, Lane DS, Lieberman D, Pope JB, Potter MB, Robin DP, Schroy PC 3rd, Smith RA.

J Gen Intern Med. 2010 Nov;25(11):1230-4. doi: 10.1007/s11606-010-1446-2. Epub 2010 Aug 12.

20.

Fecal occult blood testing beliefs and practices of U.S. primary care physicians: serious deviations from evidence-based recommendations.

Nadel MR, Berkowitz Z, Klabunde CN, Smith RA, Coughlin SS, White MC.

J Gen Intern Med. 2010 Aug;25(8):833-9. doi: 10.1007/s11606-010-1328-7. Epub 2010 Apr 10.

21.

Hormone therapy and fatal breast cancer.

Norman SA, Weber AL, Localio AR, Marchbanks PA, Ursin G, Strom BL, Weiss LK, Burkman RT, Bernstein L, Deapen DM, Folger SG, Simon MS, Nadel MR.

Pharmacoepidemiol Drug Saf. 2010 May;19(5):440-7. doi: 10.1002/pds.1941.

22.

Colorectal cancer screening by primary care physicians: recommendations and practices, 2006-2007.

Klabunde CN, Lanier D, Nadel MR, McLeod C, Yuan G, Vernon SW.

Am J Prev Med. 2009 Jul;37(1):8-16. doi: 10.1016/j.amepre.2009.03.008. Epub 2009 May 13.

23.

Assessment of the quality of colonoscopy reports: results from a multicenter consortium.

Lieberman DA, Faigel DO, Logan JR, Mattek N, Holub J, Eisen G, Morris C, Smith R, Nadel M.

Gastrointest Endosc. 2009 Mar;69(3 Pt 2):645-53. doi: 10.1016/j.gie.2008.08.034.

24.

Colorectal cancer test use from the 2005 National Health Interview Survey.

Shapiro JA, Seeff LC, Thompson TD, Nadel MR, Klabunde CN, Vernon SW.

Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1623-30. doi: 10.1158/1055-9965.EPI-07-2838.

25.

Assessment of the scientific soundness of clinical performance measures: a field test of the National Committee for Quality Assurance's colorectal cancer screening measure.

Schneider EC, Nadel MR, Zaslavsky AM, McGlynn EA.

Arch Intern Med. 2008 Apr 28;168(8):876-82. doi: 10.1001/archinte.168.8.876.

PMID:
18443264
26.

Development of a federally funded demonstration colorectal cancer screening program.

Seeff LC, DeGroff A, Tangka F, Wanliss E, Major A, Nadel M, Ryerson AB, Royalty J, Gelb C, Reed E.

Prev Chronic Dis. 2008 Apr;5(2):A64. Epub 2008 Mar 15.

27.

Cost of starting colorectal cancer screening programs: results from five federally funded demonstration programs.

Tangka FK, Subramanian S, Bapat B, Seeff LC, DeGroff A, Gardner J, Ryerson AB, Nadel M, Royalty J.

Prev Chronic Dis. 2008 Apr;5(2):A47. Epub 2008 Mar 15.

28.

Beliefs, risk perceptions, and gaps in knowledge as barriers to colorectal cancer screening in older adults.

Berkowitz Z, Hawkins NA, Peipins LA, White MC, Nadel MR.

J Am Geriatr Soc. 2008 Feb;56(2):307-14. Epub 2007 Dec 7.

PMID:
18070002
29.

Colorectal cancer screening: a comparison of 35 initiatives in 17 countries.

Benson VS, Patnick J, Davies AK, Nadel MR, Smith RA, Atkin WS; International Colorectal Cancer Screening Network.

Int J Cancer. 2008 Mar 15;122(6):1357-67.

30.

Characterizing the cancer genome in lung adenocarcinoma.

Weir BA, Woo MS, Getz G, Perner S, Ding L, Beroukhim R, Lin WM, Province MA, Kraja A, Johnson LA, Shah K, Sato M, Thomas RK, Barletta JA, Borecki IB, Broderick S, Chang AC, Chiang DY, Chirieac LR, Cho J, Fujii Y, Gazdar AF, Giordano T, Greulich H, Hanna M, Johnson BE, Kris MG, Lash A, Lin L, Lindeman N, Mardis ER, McPherson JD, Minna JD, Morgan MB, Nadel M, Orringer MB, Osborne JR, Ozenberger B, Ramos AH, Robinson J, Roth JA, Rusch V, Sasaki H, Shepherd F, Sougnez C, Spitz MR, Tsao MS, Twomey D, Verhaak RG, Weinstock GM, Wheeler DA, Winckler W, Yoshizawa A, Yu S, Zakowski MF, Zhang Q, Beer DG, Wistuba II, Watson MA, Garraway LA, Ladanyi M, Travis WD, Pao W, Rubin MA, Gabriel SB, Gibbs RA, Varmus HE, Wilson RK, Lander ES, Meyerson M.

Nature. 2007 Dec 6;450(7171):893-8. Epub 2007 Nov 4.

31.

Protection of mammography screening against death from breast cancer in women aged 40-64 years.

Norman SA, Russell Localio A, Weber AL, Coates RJ, Zhou L, Bernstein L, Malone KE, Marchbanks PA, Weiss LK, Lee NC, Nadel MR.

Cancer Causes Control. 2007 Nov;18(9):909-18. Epub 2007 Jul 31.

PMID:
17665313
32.

Standardized colonoscopy reporting and data system: report of the Quality Assurance Task Group of the National Colorectal Cancer Roundtable.

Lieberman D, Nadel M, Smith RA, Atkin W, Duggirala SB, Fletcher R, Glick SN, Johnson CD, Levin TR, Pope JB, Potter MB, Ransohoff D, Rex D, Schoen R, Schroy P, Winawer S.

Gastrointest Endosc. 2007 May;65(6):757-66. Review.

PMID:
17466195
33.

Benefit of screening mammography in reducing the rate of late-stage breast cancer diagnoses (United States).

Norman SA, Localio AR, Zhou L, Weber AL, Coates RJ, Malone KE, Bernstein L, Marchbanks PA, Liff JM, Lee NC, Nadel MR.

Cancer Causes Control. 2006 Sep;17(7):921-9.

PMID:
16841259
34.

Associations of subsite-specific colorectal cancer incidence rates and stage of disease at diagnosis with county-level poverty, by race and sex.

Wu X, Cokkinides V, Chen VW, Nadel M, Ren Y, Martin J, Ellison GL.

Cancer. 2006 Sep 1;107(5 Suppl):1121-7.

35.

Rapid quantitative analysis using a single molecule counting approach.

D'Antoni CM, Fuchs M, Harris JL, Ko HP, Meyer RE, Nadel ME, Randall JD, Rooke JE, Nalefski EA.

Anal Biochem. 2006 May 1;352(1):97-109. Epub 2006 Feb 10.

PMID:
16549054
36.

Colorectal cancer test use among Hispanic and non-Hispanic U.S. populations.

Pollack LA, Blackman DK, Wilson KM, Seeff LC, Nadel MR.

Prev Chronic Dis. 2006 Apr;3(2):A50. Epub 2006 Mar 15.

37.

A single-molecule method for the quantitation of microRNA gene expression.

Neely LA, Patel S, Garver J, Gallo M, Hackett M, McLaughlin S, Nadel M, Harris J, Gullans S, Rooke J.

Nat Methods. 2006 Jan;3(1):41-6.

PMID:
16369552
38.

Effects of interchanging hyperopic defocus and form deprivation stimuli in normal and optic nerve-sectioned chicks.

Choh V, Lew MY, Nadel MW, Wildsoet CF.

Vision Res. 2006 Mar;46(6-7):1070-9. Epub 2005 Oct 4.

39.

Refining an "opt in" approach.

Nadel MS.

Am J Bioeth. 2004 Fall;4(4):51-2; discussion W35-7. No abstract available.

PMID:
16192207
40.

Barriers to colorectal cancer screening: a comparison of reports from primary care physicians and average-risk adults.

Klabunde CN, Vernon SW, Nadel MR, Breen N, Seeff LC, Brown ML.

Med Care. 2005 Sep;43(9):939-44.

PMID:
16116360
41.

Using reciprocity to motivate organ donations.

Nadel MS, Nadel CA.

Yale J Health Policy Law Ethics. 2005 Winter;5(1):293-325. No abstract available.

PMID:
15742579
42.

A national survey of primary care physicians' methods for screening for fecal occult blood.

Nadel MR, Shapiro JA, Klabunde CN, Seeff LC, Uhler R, Smith RA, Ransohoff DF.

Ann Intern Med. 2005 Jan 18;142(2):86-94.

PMID:
15657156
43.

Workgroup III: facilitating screening for colorectal cancer: quality assurance and evaluation. UICC International Workshop on Facilitating Screening for Colorectal Cancer, Oslo, Norway (29 and 30 June 2002).

Patnick J, Ransohoff D, Atkin W, Borras JM, Elwood M, Hoff G, Nadel M, Russo A, Simon J, Weiderpass E, Zappa M, Smith R.

Ann Oncol. 2005 Jan;16(1):34-7. No abstract available. Erratum in: Ann Oncol. 2005 Jun;16(6):993. Weiderpass-Vaino, E [corrected to Weiderpass, E].

PMID:
15598934
44.

How many endoscopies are performed for colorectal cancer screening? Results from CDC's survey of endoscopic capacity.

Seeff LC, Richards TB, Shapiro JA, Nadel MR, Manninen DL, Given LS, Dong FB, Winges LD, McKenna MT.

Gastroenterology. 2004 Dec;127(6):1670-7.

PMID:
15578503
45.

Is there endoscopic capacity to provide colorectal cancer screening to the unscreened population in the United States?

Seeff LC, Manninen DL, Dong FB, Chattopadhyay SK, Nadel MR, Tangka FK, Molinari NA.

Gastroenterology. 2004 Dec;127(6):1661-9.

PMID:
15578502
46.

Testing for prostate and colorectal cancer: comparison of self-report and medical record audit.

Hall HI, Van Den Eeden SK, Tolsma DD, Rardin K, Thompson T, Hughes Sinclair A, Madlon-Kay DJ, Nadel M.

Prev Med. 2004 Jul;39(1):27-35.

PMID:
15207983
47.

Measures for ascertaining use of colorectal cancer screening in behavioral, health services, and epidemiologic research.

Vernon SW, Meissner H, Klabunde C, Rimer BK, Ahnen DJ, Bastani R, Mandelson MT, Nadel MR, Sheinfeld-Gorin S, Zapka J.

Cancer Epidemiol Biomarkers Prev. 2004 Jun;13(6):898-905. No abstract available.

48.

Patterns and predictors of colorectal cancer test use in the adult U.S. population.

Seeff LC, Nadel MR, Klabunde CN, Thompson T, Shapiro JA, Vernon SW, Coates RJ.

Cancer. 2004 May 15;100(10):2093-103.

49.

Socioeconomic differences in cancer screening participation: comparing cognitive and psychosocial explanations.

Wardle J, McCaffery K, Nadel M, Atkin W.

Soc Sci Med. 2004 Jul;59(2):249-61.

PMID:
15110417
50.

Acceptance of flexible sigmoidoscopy screening for colorectal cancer.

Montaño DE, Selby JV, Somkin CP, Bhat A, Nadel M.

Cancer Detect Prev. 2004;28(1):43-51.

PMID:
15041077

Supplemental Content

Loading ...
Support Center